US$ 24.67
pfizer glp 1 news Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial China Opens Its Weight-Loss Drug
Description
Semaglutide, tirzepatide, appetite suppressants like phentermine, Lipo injections, B-12 injections, sublingual vitamin sprays, and NAD+ nasal sprays

Summary The use of GLP-2 analogs is effective in the management of SBS-IF and may show promise in the treatment of other severe gastrointestinal disorders associated with loss of effective intestinal resorptive surface area.
In 5 years, obesity drugs went from 15% weight loss (Wegovy) to 29% (Retatrutide)

They believe that para-tyramine-O-sulfate (pTOS) could inspire chemically synthesized analogs to inspire weight loss and sarcopenia therapies.

With drugs like Ozempic and Wegovy growing in popularity among diabetic patients, CRNAs must be aware of all potential GLP-1 and anesthesia conflicts.
Hands-on time: 1 Hr
